Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Eli Lilly and Company (LLY)

84.18 -0.24 (-0.28%)

3/24/2017  4:03pm

Open:

84.30

Pre. Close:

84.42

High:

84.98

Low:

83.86

Volume:

2,479,097

Market Cap:

88.46B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

85.16 - 85.55

85.55 - 85.94

Low:

82.74 - 83.22

83.22 - 83.7

Close:

83.38 - 84.06

84.06 - 84.74

Technical analysis  (as of: 2017-03-24 4:36:39 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 100.61     One year: 117.51

Support:

Support1: 82.39    Support2: 80.07

Resistance:

Resistance1: 86.14    Resistance2: 100.61

Pivot:

84.20

Moving Averages:

MA(5): 84.15     MA(20): 83.97

MA(100): 76.09     MA(250): 76.27

MACD:

MACD(12,26): 1.21     Signal(12,26,9): 1.50

%K %D:

%K(14,3): 61.84     %D(3): 58.91

RSI:

RSI(14): 59.70

52-Week:

High: 86.14  Low: 64.18  Change(%): 20.5

Average Vol(K):

3-Month: 4030  10-Days 3545

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
LLY has closed above bottom band by 49.1%. Bollinger Bands are 65.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to LLY's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 24 Mar 2017 12:09:41 GMT
Eli Lilly to spend $85M on Indy manufacturing facility

Mon, 13 Mar 2017 20:23:09 GMT
Better Buy: Eli Lilly and Company vs. Pfizer

Sat, 25 Feb 2017 13:52:30 GMT
Better Buy: Eli Lilly and Co vs. GlaxoSmithKline plc

Mon, 20 Mar 2017 01:24:06 GMT
Canada Prevails In $383M Eli Lilly Case

Thu, 23 Feb 2017 22:17:43 GMT
Eli Lilly & Co.'s Revenues in 4Q16

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

1050.00

Shares Float (M)

923.39

% Held by Insiders

11.81

% Held by Institutions

65.90

Shares Short (K)

12150

Shares Short Prior Month (K)

12370

Stock Financials

EPS

2.580

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

13.330

PEG Ratio

1.68

Profit Margin

12.90

Operating Margin

18.24

Return on Assets (ttm)

6.5

Return on Equity (ttm)

19.1

Qtrly Rev. Growth

7.2

Gross Profit (p.s.)

14.829

Sales Per Share

20.210

EBITDA (p.s.)

5.114

Qtrly Earnings Growth

61.30

Operating Cash Flow (M)

4850.00

Levered Free Cash Flow (M)

2850.00

FoxReading.com

Valuation

P/E

32.63

P/E Growth Ratio

P/BV

6.32

P/S

4.17

P/CF

18.22

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2017-03-10

Ex-Dividend Date

2017-02-13

Forward Dividend

2.080

Last Split Date

Last Split Ratio

2

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.